Nxera Pharma Co Ltd (FRA:JSS)
€ 8.75 -0.3 (-3.31%) Market Cap: 793.19 Mil Enterprise Value: 946.53 Mil PE Ratio: 0 PB Ratio: 2.12 GF Score: 65/100

Sosei Group Corp R&D Day Transcript

Oct 13, 2022 / 06:30AM GMT
Release Date Price: €12.9 (-0.77%)
Hironoshin Nomura
Sosei Group Corporation - Senior VP of IR, VP & Corporate Strategy, Executive Officer and CFO

[Interpreted] We'll now start the R&D Day of Sosei Group. Thank you very much for taking time out of your busy schedule to attend this R&D Day today. I am Nomura, CFO, and I will serve as the moderator. Outside of this room, we have some retail investors participating online. Thank you very much the individual investors also for participating.

We have camera at the back of the room. Camera will only shoot the stage and so you will not be in the photo. So our R&D, as Chris will explain later, this R&D Day is the first time in 3 years. COVID-related restriction is finally lifted, and we can now welcome foreign travelers too, so we are having this for the first time in 3 years.

So today's program, as already been informed, first, the business overview and then the R&D and pipeline update. And lastly, some in-house program. The presentation will be a little over 1 hour, followed by Q&A. We plan to end at 5:30.

(Operator Instructions) We will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot